Hematologic Malignancy
B Lymphoblastic Lymphoma
CI-CAN-00001857Explore in graph →
Hematologic9 active trials
- NCIt
- C8868
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00001857Explore in graph →
Clinical trials
13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06710418 | Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia | recruiting | N/A | 50 | University of WashingtonOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT06355739 | CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ | recruiting | N/A | 60 | Zhu XiaofanOTHER | 1 |
| Apr 9, 2024 |
| clinicaltrials |
Data updated 22 days agoSource updated Aug 19, 2026source: clinicaltrials